DYN
Price:
$33.03
Market Cap:
$3.32B
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..[Read more]
Industry
Biotechnology
IPO Date
2020-09-17
Stock Exchange
NASDAQ
Ticker
DYN
According to Dyne Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -68.85%. This represents a change of 104.41% compared to the average of -33.68% of the last 4 quarters.
The mean historical ROE of Dyne Therapeutics, Inc. over the last ten years is -43.67%. The current -68.85% ROE has changed 57.67% with respect to the historical average. Over the past ten years (40 quarters), DYN's ROE was at its highest in in the March 2017 quarter at 24.61%. The ROE was at its lowest in in the December 2017 quarter at -74.22%.
Average
-43.67%
Median
-28.85%
Minimum
-258.44%
Maximum
98.61%
Discovering the peaks and valleys of Dyne Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.37%
Maximum Annual ROE = 98.61%
Minimum Annual Increase = -3647.54%
Minimum Annual ROE = -258.44%
Year | ROE | Change |
---|---|---|
2023 | -258.44% | 294.71% |
2022 | -65.48% | 61.49% |
2021 | -40.54% | 136.33% |
2020 | -17.16% | -82.21% |
2019 | -96.44% | -197.80% |
2018 | 98.61% | 2.37% |
2017 | 4.00% | -106.58% |
2016 | -60.72% | -3647.54% |
2015 | 1.71% | -177.23% |
2014 | -2.22% | -86.24% |
The current ROE of Dyne Therapeutics, Inc. (DYN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-121.49%
5-year avg
-95.61%
10-year avg
-43.67%
Dyne Therapeutics, Inc.’s ROE is greater than Stoke Therapeutics, Inc. (-57.89%), greater than Pliant Therapeutics, Inc. (-41.05%), less than Cytokinetics, Incorporated (196.01%), greater than Revolution Medicines, Inc. (-34.57%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Mineralys Therapeutics, Inc. (-42.61%), greater than DICE Therapeutics, Inc. (-102.37%), greater than Karuna Therapeutics, Inc. (-30.79%), greater than Gracell Biotechnologies Inc. (-37.20%), greater than Theseus Pharmaceuticals, Inc. (-24.51%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than Design Therapeutics, Inc. (-18.48%), greater than Erasca, Inc. (-131.94%),
Company | ROE | Market cap |
---|---|---|
-57.89% | $773.92M | |
-41.05% | $782.51M | |
196.01% | $6.36B | |
-34.57% | $6.99B | |
-28.01% | $1.64B | |
-28.37% | $1.04B | |
-42.61% | $558.43M | |
-102.37% | $2.27B | |
-30.79% | $12.60B | |
-37.20% | $989.87M | |
-24.51% | $181.50M | |
-70.40% | $349.21M | |
-18.48% | $264.42M | |
-131.94% | $807.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dyne Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Dyne Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Dyne Therapeutics, Inc.'s ROE?
How is the ROE calculated for Dyne Therapeutics, Inc. (DYN)?
What is the highest ROE for Dyne Therapeutics, Inc. (DYN)?
What is the 3-year average ROE for Dyne Therapeutics, Inc. (DYN)?
What is the 5-year average ROE for Dyne Therapeutics, Inc. (DYN)?
How does the current ROE for Dyne Therapeutics, Inc. (DYN) compare to its historical average?